Stone Management Device Market Size, Share & Trend Analysis - Global - 2025-2031 - Includes: ESWL Equipment Market, Stone Management Laser Market, and 3 more
Description
Global Stone Management Device Market Report, 2025 Edition
Executive Summary
The global stone management device market was valued at over $1.2 billion in 2024. The market is projected to grow at an 8.2 percent CAGR to reach nearly $2.2 billion by 2032, supported by rising kidney stone prevalence, increasing rates of obesity, expanded adoption of thulium lasers, and wider use of minimally invasive stone removal techniques.
This report covers the complete spectrum of stone management technologies, including extracorporeal shockwave lithotripsy (ESWL) capital equipment, holmium and thulium laser capital equipment and fibers, stone fragment retrieval devices, access sheaths, and ureteral stents. It quantifies units sold, average selling prices, market values, growth rates, and company shares. The analysis also reviews procedural drivers, reimbursement influence, product innovations, competitive dynamics, and technology trends. Historical data to 2022 and forecasts to 2032 are included.
The market continues to shift toward laser-based intracorporeal technologies. Holmium laser continues to dominate procedure volumes; however, thulium laser is rapidly gaining traction and is expected to grow at a double-digit rate. This transition is driven by improved energy delivery, smoother stone ablation performance, and favorable clinical results.
Stone disease remains a major global health concern. Urolithiasis prevalence ranges from 7 to 13 percent in North America, 5 to 9 percent in Europe, and up to 19 percent in West, Southeast, and South Asia, with similar rates reported in Japan and South Korea. As these rates increase, particularly among aging and obese populations, the demand for stone management devices grows across all care settings.
This report provides comprehensive strategic insights for manufacturers, distributors, investors, and hospital decision-makers evaluating the current and future landscape of the global stone management market.
Market Overview
Stone management devices support the treatment of kidney, ureteral, and bladder stones. Technologies address different clinical needs across minimally invasive, non-invasive, and intracorporeal pathways. The market includes:
Non-invasive ESWL capital equipment
Intracorporeal laser systems including holmium and thulium
Laser fibers and accessories
Stone fragment retrieval devices
Ureteral access sheaths
Ureteral stents
Holmium laser systems are still the most widely used intracorporeal modality worldwide. However, thulium laser systems have gained adoption due to their improved efficiency, consistent fragmentation, and clinical performance advantages. Thulium units represent a growing portion of capital expenditures as hospitals replace aging holmium systems or expand their laser suites.
The rise of retrograde intrarenal surgery and flexible ureteroscopy has increased demand for access sheaths, laser fibers, and retrieval devices. Clinicians increasingly favor minimally invasive techniques that reduce complication risks, shorten recovery times, and align with value-based purchasing principles.
Kidney stone disease is closely linked to aging and obesity, both of which continue to increase globally. Higher sodium intake, high-protein diets, reduced hydration levels, and metabolic disorders contribute to the rising stone burden. This supports sustained demand for stents, retrieval devices, laser fibers, and capital equipment.
Although innovation drives growth, certain market segments, such as stainless-steel retrieval devices, face commoditization. At the same time, intracorporeal laser procedures require skill, and the associated learning curve influences adoption speed. Nonetheless, demographic, epidemiological, and technological changes support a strong long-term outlook.
Market Drivers
Hospital Value-Based Purchasing Program
The Centers for Medicare and Medicaid Services hospital value-based purchasing program rewards hospitals based on quality metrics rather than quantity of care. Hospitals are graded on achievement and improvement scores, and a portion of payments is redistributed based on performance.
This encourages hospitals to select treatment modalities that minimize complications, reduce readmissions, and support efficient patient recovery. Minimally invasive and non-invasive stone removal techniques, such as laser lithotripsy and ESWL, align with these goals. As institutions place greater emphasis on quality scores, demand for technologies that reduce complication risks is expected to increase.
Demographic Factors
Kidney stone prevalence increases with age. As the global elderly population grows, especially in developed markets with aging baby boomer demographics, more patients require stone removal procedures. The link between age and stone formation supports rising future procedural volumes.
In addition, obesity is strongly associated with kidney stones. High BMI, increased waist size, and weight gain all elevate stone formation risk. As global obesity trends continue, especially in regions with high consumption of sodium and sugar, the incidence of kidney stones will rise.
Urolithiasis is a significant global health concern. The prevalence ranges from 7 to 13 percent in North America, 5 to 9 percent in Europe, and up to 19 percent in West, Southeast, and South Asia. Stone disease negatively affects quality of life and leads to increased healthcare costs. These high prevalence levels support expanding use of stone management devices.
Growing Incidence of Obesity
Dietary trends also contribute to stone formation. Diets high in protein, sodium, and sugar elevate urinary stone risk. As global food patterns continue shifting toward processed and high-sodium foods, the prevalence of kidney stones is expected to increase. Growth in stone incidence reinforces long-term demand for minimally invasive stone treatment devices, including lasers, access sheaths, stents, and retrieval products.
Together, these demographic and lifestyle factors form the foundation of sustained stone management device demand across all global regions.
Market Limiters
Commoditization
Stainless-steel stone fragment retrieval devices have existed for decades, and the category has become highly commoditized. Multiple suppliers offer similar products, resulting in declining average selling prices. Unit growth in this category has remained weak, limiting overall market expansion for retrieval devices.
Commoditization also reduces manufacturer differentiation and compresses margins, prompting companies to focus on value-added devices and disposable products with stronger pricing power.
Learning Curve for Laser Procedures
Laser lithotripsy requires training and experience. Urologists must develop skill using holmium or thulium fibers within confined anatomical spaces. These techniques require precision, and mastering efficient laser technique can take substantial time. Because training availability varies worldwide, adoption may be slower in regions without widespread access to laser education programs.
Despite this, skilled clinicians favor laser procedures due to their flexibility and success rates. As more programs integrate laser training into residency and fellowship pathways, this barrier may gradually decline.
Invasiveness of Intracorporeal Procedures
Intracorporeal procedures, such as percutaneous nephrolithotomy (PCNL), are more invasive than ESWL or ureteroscopy. They carry risks of bleeding, infection, and other complications. PCNL requires puncturing the skin and inserting a catheter at the renal pelvis. These risks may deter patients from pursuing the procedure unless medically necessary.
Under value-based purchasing initiatives, hospitals may be cautious about adopting tools that support more invasive procedures if complication risks create penalties. In cases where kidney damage risk increases, however, intracorporeal approaches remain essential.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts through 2032
Growth rates
Units sold
Average selling prices
Qualitative Coverage
Market growth trends
Market limiters
Competitive landscape and SWOT analyses
Company profiles and product portfolios
Mergers and acquisitions
Regulatory and reimbursement influences
Disease and clinical pathway overviews
Data Sources
Primary interviews with industry executives and urology specialists
Government physician and procedural data
Import and export records
Regulatory filings
Hospital procurement databases
iData Research’s internal datasets and forecasting models
Markets Covered and Segmentation
Global Stone Management Device Market Segmentation
ESWL capital equipment
Holmium laser capital equipment and fibers
Thulium laser capital equipment and fibers
Stone fragment retrieval devices
Ureteral access sheaths
Ureteral stents
Each segment includes market value, unit sales, and ASP trends across all global regions.
Competitive Analysis
Boston Scientific
Boston Scientific was the leading competitor in the global stone treatment device market in 2024. The company distributes the Swiss LithoClast family of pneumatic, ultrasonic, and combination ISWL capital equipment. Its FlexProbe device is used for flexible endoscopy during kidney, ureteral, and bladder procedures.
Boston Scientific also offers an extensive portfolio of holmium laser fibers, including Accumax, Flexiva, SlimLine EZ, and VersaPulse PowerSuite accessories. In September 2024, Boston Scientific completed its acquisition of the global surgical business of Lumenis, significantly strengthening its position in laser lithotripsy and expanding its footprint across hospitals and ambulatory surgery centers.
Cook Medical
Cook Medical ranked second in the global stone management market in 2024. The company holds strong positions in stone fragment retrieval and ureteral stent markets. Cook’s notable retrieval devices include NForces, NCompass, and NGage nitinol extractors, along with a comprehensive set of ureteral stents such as the Resonance, C Flex, Sof-Flex, and Universa lines.
Cook Medical also maintains a significant presence in the ISWL and holmium laser markets. The depth of Cook’s urology portfolio and broad geographic reach contribute to its competitive strength.
Olympus
Olympus was the third-leading competitor in 2024. The company leads the global thulium laser market and holds the second-largest position in the ISWL and holmium laser categories. Olympus is recognized for its advanced laser platforms and strong relationships with urologists worldwide.
By providing high-performance thulium laser systems, Olympus has gained adoption among clinicians who value smooth fragmentation and precision. Olympus also competes with a wide range of complementary urology tools, supporting cross-category penetration.
Technology and Practice Trends
Growing adoption of thulium laser systems due to superior ablation characteristics
Continued preference for holmium lasers as the clinical standard in many facilities
Expansion of retrograde intrarenal surgery and flexible ureteroscopy
Improved laser fiber durability and performance
Increasing use of disposable retrieval devices for infection control and workflow efficiency
Integration of digital visualization systems to guide intracorporeal lithotripsy
Higher utilization of access sheaths to improve procedural efficiency
More emphasis on reducing complication risks under value-based care models
These trends collectively support ongoing investment in capital equipment, consumables, and disposable lithotripsy tools.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where the fastest-growing opportunities exist in ESWL, lasers, retrieval devices, access sheaths, and stents
How demographic factors such as aging and obesity influence long-term demand
How thulium lasers will shift the competitive landscape
How commoditization affects retrieval devices and pricing strategies
How clinicians select intracorporeal vs non-invasive modalities under value-based purchasing
What competitive strengths drive growth for Boston Scientific, Cook Medical, and Olympus
How device life cycles, training requirements, and procedural preferences influence market trends
How suppliers can position their products based on safety, workflow efficiency, and clinical outcomes
The Global Stone Management Device Market Report from iData Research enables leaders to quantify the market, plan product strategies, evaluate pricing dynamics, and analyze competitive strength across global regions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global stone management device market was valued at over $1.2 billion in 2024. The market is projected to grow at an 8.2 percent CAGR to reach nearly $2.2 billion by 2032, supported by rising kidney stone prevalence, increasing rates of obesity, expanded adoption of thulium lasers, and wider use of minimally invasive stone removal techniques.
This report covers the complete spectrum of stone management technologies, including extracorporeal shockwave lithotripsy (ESWL) capital equipment, holmium and thulium laser capital equipment and fibers, stone fragment retrieval devices, access sheaths, and ureteral stents. It quantifies units sold, average selling prices, market values, growth rates, and company shares. The analysis also reviews procedural drivers, reimbursement influence, product innovations, competitive dynamics, and technology trends. Historical data to 2022 and forecasts to 2032 are included.
The market continues to shift toward laser-based intracorporeal technologies. Holmium laser continues to dominate procedure volumes; however, thulium laser is rapidly gaining traction and is expected to grow at a double-digit rate. This transition is driven by improved energy delivery, smoother stone ablation performance, and favorable clinical results.
Stone disease remains a major global health concern. Urolithiasis prevalence ranges from 7 to 13 percent in North America, 5 to 9 percent in Europe, and up to 19 percent in West, Southeast, and South Asia, with similar rates reported in Japan and South Korea. As these rates increase, particularly among aging and obese populations, the demand for stone management devices grows across all care settings.
This report provides comprehensive strategic insights for manufacturers, distributors, investors, and hospital decision-makers evaluating the current and future landscape of the global stone management market.
Market Overview
Stone management devices support the treatment of kidney, ureteral, and bladder stones. Technologies address different clinical needs across minimally invasive, non-invasive, and intracorporeal pathways. The market includes:
Non-invasive ESWL capital equipment
Intracorporeal laser systems including holmium and thulium
Laser fibers and accessories
Stone fragment retrieval devices
Ureteral access sheaths
Ureteral stents
Holmium laser systems are still the most widely used intracorporeal modality worldwide. However, thulium laser systems have gained adoption due to their improved efficiency, consistent fragmentation, and clinical performance advantages. Thulium units represent a growing portion of capital expenditures as hospitals replace aging holmium systems or expand their laser suites.
The rise of retrograde intrarenal surgery and flexible ureteroscopy has increased demand for access sheaths, laser fibers, and retrieval devices. Clinicians increasingly favor minimally invasive techniques that reduce complication risks, shorten recovery times, and align with value-based purchasing principles.
Kidney stone disease is closely linked to aging and obesity, both of which continue to increase globally. Higher sodium intake, high-protein diets, reduced hydration levels, and metabolic disorders contribute to the rising stone burden. This supports sustained demand for stents, retrieval devices, laser fibers, and capital equipment.
Although innovation drives growth, certain market segments, such as stainless-steel retrieval devices, face commoditization. At the same time, intracorporeal laser procedures require skill, and the associated learning curve influences adoption speed. Nonetheless, demographic, epidemiological, and technological changes support a strong long-term outlook.
Market Drivers
Hospital Value-Based Purchasing Program
The Centers for Medicare and Medicaid Services hospital value-based purchasing program rewards hospitals based on quality metrics rather than quantity of care. Hospitals are graded on achievement and improvement scores, and a portion of payments is redistributed based on performance.
This encourages hospitals to select treatment modalities that minimize complications, reduce readmissions, and support efficient patient recovery. Minimally invasive and non-invasive stone removal techniques, such as laser lithotripsy and ESWL, align with these goals. As institutions place greater emphasis on quality scores, demand for technologies that reduce complication risks is expected to increase.
Demographic Factors
Kidney stone prevalence increases with age. As the global elderly population grows, especially in developed markets with aging baby boomer demographics, more patients require stone removal procedures. The link between age and stone formation supports rising future procedural volumes.
In addition, obesity is strongly associated with kidney stones. High BMI, increased waist size, and weight gain all elevate stone formation risk. As global obesity trends continue, especially in regions with high consumption of sodium and sugar, the incidence of kidney stones will rise.
Urolithiasis is a significant global health concern. The prevalence ranges from 7 to 13 percent in North America, 5 to 9 percent in Europe, and up to 19 percent in West, Southeast, and South Asia. Stone disease negatively affects quality of life and leads to increased healthcare costs. These high prevalence levels support expanding use of stone management devices.
Growing Incidence of Obesity
Dietary trends also contribute to stone formation. Diets high in protein, sodium, and sugar elevate urinary stone risk. As global food patterns continue shifting toward processed and high-sodium foods, the prevalence of kidney stones is expected to increase. Growth in stone incidence reinforces long-term demand for minimally invasive stone treatment devices, including lasers, access sheaths, stents, and retrieval products.
Together, these demographic and lifestyle factors form the foundation of sustained stone management device demand across all global regions.
Market Limiters
Commoditization
Stainless-steel stone fragment retrieval devices have existed for decades, and the category has become highly commoditized. Multiple suppliers offer similar products, resulting in declining average selling prices. Unit growth in this category has remained weak, limiting overall market expansion for retrieval devices.
Commoditization also reduces manufacturer differentiation and compresses margins, prompting companies to focus on value-added devices and disposable products with stronger pricing power.
Learning Curve for Laser Procedures
Laser lithotripsy requires training and experience. Urologists must develop skill using holmium or thulium fibers within confined anatomical spaces. These techniques require precision, and mastering efficient laser technique can take substantial time. Because training availability varies worldwide, adoption may be slower in regions without widespread access to laser education programs.
Despite this, skilled clinicians favor laser procedures due to their flexibility and success rates. As more programs integrate laser training into residency and fellowship pathways, this barrier may gradually decline.
Invasiveness of Intracorporeal Procedures
Intracorporeal procedures, such as percutaneous nephrolithotomy (PCNL), are more invasive than ESWL or ureteroscopy. They carry risks of bleeding, infection, and other complications. PCNL requires puncturing the skin and inserting a catheter at the renal pelvis. These risks may deter patients from pursuing the procedure unless medically necessary.
Under value-based purchasing initiatives, hospitals may be cautious about adopting tools that support more invasive procedures if complication risks create penalties. In cases where kidney damage risk increases, however, intracorporeal approaches remain essential.
Market Coverage and Data Scope
Quantitative Coverage
Market size
Market shares
Market forecasts through 2032
Growth rates
Units sold
Average selling prices
Qualitative Coverage
Market growth trends
Market limiters
Competitive landscape and SWOT analyses
Company profiles and product portfolios
Mergers and acquisitions
Regulatory and reimbursement influences
Disease and clinical pathway overviews
Data Sources
Primary interviews with industry executives and urology specialists
Government physician and procedural data
Import and export records
Regulatory filings
Hospital procurement databases
iData Research’s internal datasets and forecasting models
Markets Covered and Segmentation
Global Stone Management Device Market Segmentation
ESWL capital equipment
Holmium laser capital equipment and fibers
Thulium laser capital equipment and fibers
Stone fragment retrieval devices
Ureteral access sheaths
Ureteral stents
Each segment includes market value, unit sales, and ASP trends across all global regions.
Competitive Analysis
Boston Scientific
Boston Scientific was the leading competitor in the global stone treatment device market in 2024. The company distributes the Swiss LithoClast family of pneumatic, ultrasonic, and combination ISWL capital equipment. Its FlexProbe device is used for flexible endoscopy during kidney, ureteral, and bladder procedures.
Boston Scientific also offers an extensive portfolio of holmium laser fibers, including Accumax, Flexiva, SlimLine EZ, and VersaPulse PowerSuite accessories. In September 2024, Boston Scientific completed its acquisition of the global surgical business of Lumenis, significantly strengthening its position in laser lithotripsy and expanding its footprint across hospitals and ambulatory surgery centers.
Cook Medical
Cook Medical ranked second in the global stone management market in 2024. The company holds strong positions in stone fragment retrieval and ureteral stent markets. Cook’s notable retrieval devices include NForces, NCompass, and NGage nitinol extractors, along with a comprehensive set of ureteral stents such as the Resonance, C Flex, Sof-Flex, and Universa lines.
Cook Medical also maintains a significant presence in the ISWL and holmium laser markets. The depth of Cook’s urology portfolio and broad geographic reach contribute to its competitive strength.
Olympus
Olympus was the third-leading competitor in 2024. The company leads the global thulium laser market and holds the second-largest position in the ISWL and holmium laser categories. Olympus is recognized for its advanced laser platforms and strong relationships with urologists worldwide.
By providing high-performance thulium laser systems, Olympus has gained adoption among clinicians who value smooth fragmentation and precision. Olympus also competes with a wide range of complementary urology tools, supporting cross-category penetration.
Technology and Practice Trends
Growing adoption of thulium laser systems due to superior ablation characteristics
Continued preference for holmium lasers as the clinical standard in many facilities
Expansion of retrograde intrarenal surgery and flexible ureteroscopy
Improved laser fiber durability and performance
Increasing use of disposable retrieval devices for infection control and workflow efficiency
Integration of digital visualization systems to guide intracorporeal lithotripsy
Higher utilization of access sheaths to improve procedural efficiency
More emphasis on reducing complication risks under value-based care models
These trends collectively support ongoing investment in capital equipment, consumables, and disposable lithotripsy tools.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Why This Report
Where the fastest-growing opportunities exist in ESWL, lasers, retrieval devices, access sheaths, and stents
How demographic factors such as aging and obesity influence long-term demand
How thulium lasers will shift the competitive landscape
How commoditization affects retrieval devices and pricing strategies
How clinicians select intracorporeal vs non-invasive modalities under value-based purchasing
What competitive strengths drive growth for Boston Scientific, Cook Medical, and Olympus
How device life cycles, training requirements, and procedural preferences influence market trends
How suppliers can position their products based on safety, workflow efficiency, and clinical outcomes
The Global Stone Management Device Market Report from iData Research enables leaders to quantify the market, plan product strategies, evaluate pricing dynamics, and analyze competitive strength across global regions.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
216 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
